Medicare Enrolled
Dr. Monica Zaki, D.O.
Neurology · Auburn Hills, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Zaki from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Zaki?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Zaki
Dr. Monica Zaki is a neurology specialist in Auburn Hills, MI, with 12 years of NPI registration. Based on federal Medicare data, Dr. Zaki performed 1,333 Medicare services across 927 unique beneficiaries.
Between the years covered by Open Payments, Dr. Zaki received a total of $18,655 from 78 pharmaceutical and/or device companies across 1021 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Zaki is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice
▲ Top 13% volume in MI
$18,655 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,333
Medicare services
Top 13% in MI for neurology
927
Unique beneficiaries
$139
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~111 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
321 | $94 | $210 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
204 | $135 | $400 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
191 | $130 | $322 |
| New patient office visit, complex (60-74 min) | 125 | $155 | $487 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
103 | $75 | $255 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
97 | $340 | $1,162 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
89 | $168 | $518 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 65 | $211 | $500 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
64 | $72 | $315 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
18 | $132 | $502 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
18 | $220 | $645 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
14 | $130 | $592 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
13 | $55 | $190 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
11 | $122 | $250 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$18,655
Total received (2018-2024)
Avg $2,665/year across 7 years
Top 16% in MI for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
78
Companies
1,021
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,490 (99.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$165 (0.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,199
2023
$5,053
2022
$3,101
2021
$3,302
2020
$1,890
2019
$693
2018
$1,418
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$272
Lilly USA, LLC
$268
Novartis Pharmaceuticals Corporation
$246
Biogen, Inc.
$236
Neurocrine Biosciences, Inc.
$220
EMD Serono, Inc.
$186
Celgene Corporation
$171
Lundbeck LLC
$152
HARMONY BIOSCIENCES LLC
$146
JAZZ PHARMACEUTICALS INC.
$140
SK Life Science, Inc.
$137
CATALYST PHARMACEUTICALS, INC.
$132
Eisai Inc.
$105
Sumitomo Pharma America, Inc.
$86
Avadel CNS Pharmaceuticals, LLC
$84
PFIZER INC.
$80
Novo Nordisk Inc
$71
ABBVIE INC.
$70
Teva Pharmaceuticals USA, Inc.
$65
Genentech USA, Inc.
$44
Axsome Therapeutics, Inc.
$35
Kyowa Kirin, Inc.
$28
ACADIA Pharmaceuticals Inc
$28
Vanda Pharmaceuticals Inc.
$26
Octapharma USA, Inc.
$25
Otsuka America Pharmaceutical, Inc.
$24
Alexion Pharmaceuticals, Inc.
$23
ARGENX US, INC.
$22
SCILEX PHARMACEUTICALS INC.
$22
ANI Pharmaceuticals, Inc.
$21
AstraZeneca Pharmaceuticals LP
$20
Aucta Pharmaceuticals, Inc.
$14
Top 3 companies account for 24.6% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$1,435
Biogen, Inc.
$1,211
Teva Pharmaceuticals USA, Inc.
$1,169
Novartis Pharmaceuticals Corporation
$914
Amgen Inc.
$895
Neurocrine Biosciences, Inc.
$694
Eisai Inc.
$687
Janssen Pharmaceuticals, Inc
$672
Celgene Corporation
$664
EMD Serono, Inc.
$656
GENZYME CORPORATION
$592
AbbVie Inc.
$475
SK Life Science, Inc.
$460
Avanir Pharmaceuticals, Inc.
$445
Adamas Pharmaceuticals, Inc.
$393
Lilly USA, LLC
$391
Harmony Biosciences LLC
$382
ABBVIE INC.
$373
Jazz Pharmaceuticals Inc.
$370
JAZZ PHARMACEUTICALS INC.
$331
Genentech USA, Inc.
$305
Neurelis, Inc.
$303
Horizon Therapeutics plc
$296
Lundbeck LLC
$294
PFIZER INC.
$288
Greenwich Biosciences, Inc.
$248
Kyowa Kirin, Inc.
$224
Biohaven Pharmaceuticals, Inc.
$199
HARMONY BIOSCIENCES LLC
$197
CATALYST PHARMACEUTICALS, INC.
$180
ACADIA Pharmaceuticals Inc
$179
UPSHER-SMITH LABORATORIES LLC
$156
E.R. Squibb & Sons, L.L.C.
$151
Sumitomo Pharma America, Inc.
$145
Axsome Therapeutics, Inc.
$138
ARGENX US, INC.
$131
Avadel CNS Pharmaceuticals, LLC
$127
NEUROPACE, INC.
$121
Corium, LLC
$110
Amneal Pharmaceuticals LLC
$109
Scilex Pharmaceuticals Inc.
$93
Alexion Pharmaceuticals, Inc.
$90
Acorda Therapeutics, Inc
$78
Sunovion Pharmaceuticals Inc.
$77
Takeda Pharmaceuticals U.S.A., Inc.
$76
BANNER LIFE SCIENCES, LLC
$76
Allergan, Inc.
$72
Biohaven Pharmaceutical Holding Company Ltd.
$71
Novo Nordisk Inc
$71
Upsher-Smith Laboratories LLC
$59
Otsuka America Pharmaceutical, Inc.
$59
US WorldMeds, LLC
$56
Avion Pharmaceuticals
$51
Resmed Corp
$46
SANOFI-AVENTIS U.S. LLC
$40
AbbVie, Inc.
$39
CSL Behring
$38
EISAI INC.
$36
Supernus Pharmaceuticals, Inc.
$30
Inspire Medical Systems, Inc.
$29
Medtronic, Inc.
$29
Currax Pharmaceuticals LLC
$28
Vanda Pharmaceuticals Inc.
$26
Octapharma USA, Inc.
$25
ARBOR PHARMACEUTICALS, INC.
$22
SCILEX PHARMACEUTICALS INC.
$22
Azurity Pharmaceuticals, Inc.
$21
TG THERAPEUTICS, INC.
$21
ANI Pharmaceuticals, Inc.
$21
AstraZeneca Pharmaceuticals LP
$20
Banner Life Sciences, LLC
$19
Medtronic USA, Inc.
$19
MDD US Operations, LLC
$18
Zyla Life Sciences, Inc.
$16
Mallinckrodt Hospital Products Inc.
$14
Aucta Pharmaceuticals, Inc.
$14
BioDelivery Sciences International, Inc.
$12
Metacel Pharmaceuticals LLC
$10
Top 3 companies account for 20.5% of all-time payments
Associated products mentioned in payments ›
ACCURIAN · ACTHAR · ADLARITY · ADUHELM · AIMOVIG · AIRSENSE · AJOVY · AMPYRA · AMYVID · APNEALINK · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BELBUCA · BOTOX · BRIUMVI · Briviact · CHANTIX · COMIRNATY · CONTRAVE · Cimzia · DUOPA · Dayvigo · Dhivy · Duopa · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GAMMAGARD · GOCOVRI · Hizentra · Horizant · INBRIJA · INGREZZA · INSPIRE · KESIMPTA · KISUNLA · LEMTRADA · LUMRYZ · Leqembi · MAVENCLAD · Mavenclad · Motpoly XR · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCREVUS · ONZETRA XSAIL · Ocrevus · Ocrevus Zunovo · Ongentys · Ozobax · PANZYGA · PAXLOVID · POMPE - DISEASE · PONVORY · PURIFIED CORTROPHIN GEL · Ponvory · QULIPTA · REXULTI · RNS System · RYTARY · Rebif · Rystiggo · SOLIRIS · SPRIX · SUNOSI · Soliris · Solitaire · Sunosi · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · Wakix · XYREM · XYWAV · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
214
Per 100K population
16.8
County median income
$95,296
Nearest hospital
HAVENWYCK HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Zaki is a clinical cardiology specialist, with above-average Medicare volume (top 13% in MI), with low-engagement industry engagement in the top 16% of MI peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Zaki experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Zaki performed 321 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Zaki receive payments from pharmaceutical companies?
Yes. Dr. Zaki received a total of $18,655 from 78 companies across 1,021 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Zaki's costs compare to other neurologists in Auburn Hills?
Dr. Zaki's average Medicare payment per service is $139. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Zaki) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Auburn Hills
Browse neurologists in Auburn Hills ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in MI
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in MI
Which MI neurologists receive the most from drug and device companies.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology